MedPath

CLOZAPINE

These highlights do not include all the information needed to use CLOZAPINE TABLETS safely and effectively. See full prescribing information for CLOZAPINE TABLETS. CLOZAPINE tablets, for oral use Initial U.S. Approval: 1989

Approved
Approval ID

9db7aefb-f607-4158-a310-181e631bc648

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2024

Manufacturers
FDA

Major Pharmaceuticals

DUNS: 191427277

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CLOZAPINE

PRODUCT DETAILS

NDC Product Code0904-7406
Application NumberANDA206433
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 4, 2024
Generic NameCLOZAPINE

INGREDIENTS (7)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CLOZAPINEActive
Quantity: 50 mg in 1 1
Code: J60AR2IKIC
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

CLOZAPINE

PRODUCT DETAILS

NDC Product Code0904-7089
Application NumberANDA206433
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 4, 2024
Generic NameCLOZAPINE

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
CLOZAPINEActive
Quantity: 25 mg in 1 1
Code: J60AR2IKIC
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT

CLOZAPINE

PRODUCT DETAILS

NDC Product Code0904-7087
Application NumberANDA206433
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 4, 2024
Generic NameCLOZAPINE

INGREDIENTS (7)

CLOZAPINEActive
Quantity: 100 mg in 1 1
Code: J60AR2IKIC
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

CLOZAPINE

PRODUCT DETAILS

NDC Product Code0904-7088
Application NumberANDA206433
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 4, 2024
Generic NameCLOZAPINE

INGREDIENTS (7)

CLOZAPINEActive
Quantity: 200 mg in 1 1
Code: J60AR2IKIC
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOZAPINE - FDA Drug Approval Details